FDA Updates Indications for Temozolomide

AI Summary

The text states that a second drug has received a labeling update under an agency's program called Project Renewal, which aims to keep the labels of older cancer drugs current.

This is the second drug to receive a labeling update under the agency’s Project Renewal program, which aims to keep labels of older cancer drugs up to date with current practice.
Medscape Medical News

Leave a Reply